Hirsutinolide-type sesquiterpenoids with anti-prostate cancer activity from Cyanthillium cinereum

被引:5
|
作者
Ang, Song [1 ,2 ,3 ]
Liu, Chun [1 ]
Hong, Peng [1 ,2 ]
Yang, Lei [1 ,2 ]
Hu, Guie [1 ]
Zheng, Xi [1 ,2 ]
Jin, Jingwei [1 ,2 ]
Wu, Rihui [1 ,2 ]
Wong, Wing-Leung [1 ]
Zhang, Kun [1 ,2 ,3 ]
Gan, Lishe [1 ,2 ]
Li, Dongli [1 ,2 ,4 ]
机构
[1] Wuyi Univ, Sch Biotechnol & Hlth Sci, Jiangmen 529020, Peoples R China
[2] Int Healthcare Innovat Inst Jiangmen, Jiangmen 529040, Peoples R China
[3] Guangdong Univ Technol, Guangzhou 510006, Peoples R China
[4] Wuyi Univ, Guangdong Prov Key Lab Large Anim Models Biomed, Jiangmen 529020, Peoples R China
基金
中国国家自然科学基金;
关键词
Hirsutinolide-type sesquiterpenoid; Anti-prostate cancer activity; Cyanthillium cinereum (L.) (Asteraceae); LACTONES; GERMACRANOLIDE; GLAUCOLIDES;
D O I
10.1016/j.phytochem.2023.113887
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Four previously undescribed hirsutinolide-type sesquiterpenoids, cyanolides A-D (1-4), along with twelve known analogues (5-16), were isolated from the aerial parts of Cyanthillium cinereum. Their structures were determined by comprehensive analysis of NMR, HRESIMS, and ECD spectra. Compound 1 is a rarely occurring hirsutinolidetype sesquiterpenoid with 1,4-ether ring ruptured and containing a chlorine atom, and compounds 13-16 were reported from this plant for the first time. All compounds were tested for their inhibiting effects on prostate cancer cells. As a result, compounds 1, 3, and 8-14 exhibited significant anti-prostate cancer activity against PC3 and LNCaP cells with IC50 values ranging from 2.2 +/- 0.4 to 8.5 +/- 0.7 mu M and 3.0 +/- 0.7 to 10.5 +/- 1.1 mu M, respectively. The preliminary structure-activity relationship was discussed. Further investigation showed that compound 1 induced apoptosis in PC-3 cells.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Anti-prostate cancer and anti-breast cancer activities of two peptides derived from alpha-fetoprotein
    Caceres, G
    Dauphinee, MJ
    Eisele, LE
    MacColl, R
    Mizejewski, GJ
    ANTICANCER RESEARCH, 2002, 22 (05) : 2817 - 2820
  • [32] RNA aptamers with anti-VEGF, anti-angiogenic and anti-prostate tumor activity
    Zhang, S
    Cheng, L
    Xu, W
    Dominguez, J
    LABORATORY INVESTIGATION, 2002, 82 (01) : 188A - 188A
  • [33] RNA aptamers with anti-VEGF, anti-angiogenic and anti-prostate tumor activity
    Zhang, S
    Cheng, L
    Xu, W
    Dominguez, J
    MODERN PATHOLOGY, 2002, 15 (01) : 188A - 188A
  • [34] A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo
    Bemis, DL
    Capodice, JL
    Desai, M
    Buttyan, R
    Katz, AE
    CLINICAL CANCER RESEARCH, 2004, 10 (15) : 5282 - 5292
  • [35] Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy
    Ma, QZ
    Safar, M
    Holmes, E
    Wang, YW
    Boynton, AL
    Junghans, RP
    PROSTATE, 2004, 61 (01): : 12 - 25
  • [36] Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61
    Sahin, Taha Koray
    Aktepe, Oktay Halit
    Uckun, Fatih Mehmet
    Yalcin, Suayib
    ANTI-CANCER DRUGS, 2020, 31 (06) : 609 - 616
  • [37] Design and synthesis of curcumin analogues as anti-prostate cancer agents.
    Lin, L
    Shi, QA
    Su, CY
    Shih, CCY
    Bastow, KF
    Lee, KH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U195 - U195
  • [38] Cabozantinib Inhibits Abiraterone's Upregulation of IGFIR Phosphorylation and Enhances Its Anti-Prostate Cancer Activity
    Wang, Xiaodong
    Huang, Ying
    Christie, Amanda
    Bowden, Michaela
    Lee, Gwo-Shu Mary
    Kantoff, Philip W.
    Sweeney, Christopher J.
    CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5578 - 5587
  • [39] SRJ23, A NEW INVESTIGATIONAL ANTI-PROSTATE CANCER AGENT
    Wong, Hui Chyn
    Sagineedu, Sreenivasa Rao
    Lajis, Nordin Haji
    Stanslas, Johnson
    FASEB JOURNAL, 2010, 24
  • [40] Investigation of the Anti-Prostate Cancer Properties of Marine-Derived Compounds
    Fan, Meiqi
    Nath, Amit Kumar
    Tang, Yujiao
    Choi, Young-Jin
    Debnath, Trishna
    Choi, Eun-Ju
    Kim, Eun-Kyung
    MARINE DRUGS, 2018, 16 (05)